Magnesium

Minerals

Brand: Catie's

Tablet or PillOff Market
Click to view full label

Net Contents

90 Tablet(s)

Serving Size

1 Tablet(s)

Servings Per Container

Not specified

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

1 85707 00012 3

Product Version

Not specified

Suggested Use

FOR OPTIMAL DAILY NUTRITION: Take 1 to 3 tablets daily or as needed. Because it is food; it can be taken anytime with or without food.

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study

    SZ Levine, J Rabinowitz, H Ascher-Svanum… - Schizophrenia …, 2011 - Elsevier

    … In CATIE, for methodological reasons, patients randomized prior to January 2002, who … CATIE allowed the use of off-label daily olanzapine doses of 22.5 or 30 mg. Doses of the other …

    201156 citations
  • CATIE News-Health agencies issue caution on saquinavir use

    SR Hosein - positivelypositive.ca

    … need to reduce the dose of saquinavir to 500 mg twice daily during the first week of use in … After the first week the dose of saquinavir is increased to the normal dose of 1,000 mg twice …

  • Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical …

    …, J Severe, JK Hsiao, Catie Investigators - American Journal of …, 2006 - psychiatryonline.org

    … Effectiveness (CATIE) investigation were randomly reassigned to double-blind treatment with a different antipsychotic (olanzapine, 7.5–30 mg/day [N=66]; quetiapine, 200–800 mg/day […

    2006608 citations
  • Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study

    AM Wessels, RR Bies, BG Pollock… - The Journal of Clinical …, 2011 - ovid.com

    … The CATIE study was initiated by the National Institute of Mental Health to determine the … olanzapine (7.5-30 mg), perphenazine (8-24 mg), quetiapine (200-800 mg), risperidone (1.5 …

    201127 citations
  • Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study

    …, JA Lieberman, CATIE Investigators - American Journal of …, 2007 - psychiatryonline.org

    … Identical-appearing capsules contained olanzapine (7.5 mg), quetiapine (200 mg), risperidone (1.5 mg), perphenazine (8 mg) or, after January 2002, ziprasidone (40 mg). Patients with …

    2007424 citations
  • Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

    GL Daumit, DC Goff, JM Meyer, VG Davis… - Schizophrenia …, 2008 - Elsevier

    … that the impact on 10-year CHD risk differs significantly between antipsychotic agents, with olanzapine producing the largest elevation in CHD risk of the agents studied in CATIE. …

    2008316 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2013-06-25. DSLD Label ID: 22134. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.